RADIOPHARM THERANOSTICS LTD (RADX) Stock Income Statement
NASDAQ:RADX
Current stock price
4.795 USD
+0.08 (+1.59%)
Last:
| TTM (2025-12-31) | 2025 (2025-6-30) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.64M | 3.63M | 299.20K | 292.40K | 0.00 | |||
| Minority Interest Expense | 2.00M | 1.64M | N/A | N/A | N/A | |||
| Cost Of Goods | 3.26M | 3.59M | N/A | N/A | N/A | |||
| Gross Profit | 373.60K | 39.30K | N/A | N/A | N/A | |||
| Operating Expenses | 41.23M | 33.79M | 37.42M | 34.52M | 19.92M | |||
| Research and Development | 35.24M | 24.93M | 19.97M | 22.03M | 4.51M | |||
| Selling, General, and Administrative Expenses | 19.39M | 16.53M | 15.67M | 15.26M | 12.44M | |||
| Operating Income | -40.85M | -33.75M | -37.12M | -34.23M | -19.92M | |||
| Interest Income/Expense | -5.95M | -4.49M | -10.73M | -343.30K | -10.46M | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -46.81M | -38.24M | -47.85M | -34.57M | -30.38M | |||
| Income Tax | 136.60K | 103.30K | 96.40K | 38.00K | 44.40K | |||
| Net Income | -44.94M | -36.70M | -47.95M | -34.61M | -30.42M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -6.97 | -8.02 | -56.54 | -48.70 | -69.79 | |||
| Statistics | ||||||||
| Gross Profit Margin | 10.28% | 1.08% | N/A | N/A | N/A | |||
| Profit Margin | -1236.26% | -1010.16% | -16025.77% | -11836.94% | N/A | |||
| Operating Profit Margin | -1123.75% | -928.95% | -12407.55% | -11706.53% | N/A | |||
All data in AUD